I uge 76 havde 84% af de patienter, der var genrandomiseret til vedligeholdelsesbehandling, et PASI 75 - respons sammenholdt med 19% af de patienter, der var genrandomiseret til placebo (behandlingsophør).
At week 76, 84% of patients re-randomised to maintenance treatment were PASI 75 responders compared with 19% of patients re-randomised to placebo (treatment withdrawal).